Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (ARD) in head and neck cancer patients (DERMISHEAD trial)"

Radiother Oncol. 2022 Apr;169:142. doi: 10.1016/j.radonc.2022.01.001. Epub 2022 Jan 19.

¹ Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China; Department of Radiation Oncology, Anhui Provincial Cancer Hospital, Hefei, People's Republic of China. Electronic address: 285441619@qq.com.
² Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China; Department of Radiation Oncology, Anhui Provincial Cancer Hospital, Hefei, People's Republic of China. Electronic address: money2004@sina.com.
³ Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China; Department of Radiation Oncology, Anhui Provincial Cancer Hospital, Hefei, People's Republic of China. Electronic address: gaojinsy@ustc.edu.cn.

No abstract available

Publication types